Active Biotech’s partner NeoTX to Present at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
Lund, November 9, 2021 - Active Biotech (NASDAQ STOCKHOLM: ACTI) and its partner NeoTX announce today a presentation on naptumomab...
Day: November 9, 2021
Athenex Announces Exclusive License Agreement with National Cancer Institute to Utilize T Cell Receptors Targeting Mutated p53, KRAS, and EGFR for the Development of Autologous and Allogeneic Cell Therapies
Athenex plans to expand the allogeneic NKT cell R&D pipeline with these new licensed TCRs to target solid tumorsBUFFALO, N.Y.,...
Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual Meeting
Press ReleaseStockholm, Sweden, November 9, 2021Immunicum to Present New Research Data at The Society for Immunotherapy of Cancer (SITC) Annual...
Immatics Reports Clinical Responses across Multiple Solid Tumor Types in Ongoing ACTengine® IMA203 Phase 1a Trial Targeting PRAME
Company to host conference call on Tuesday, November 9 at 8:30 am EST Dose escalation for cell therapy candidate ACTengine®...
Neoleukin Therapeutics to Present at Upcoming Investor Conferences
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Neoleukin Therapeutics, Inc., “Neoleukin” (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to...
Kane Biotech to Release Third Quarter 2021 Financial Results on November 16 – Conference Call to Follow
WINNIPEG, Manitoba, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a...
Jounce Therapeutics to Present at Upcoming Investor Conferences in November
CAMBRIDGE, Mass., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery...
Oncorus Announces Details of Upcoming ONCR-177 Phase 1 Initial Clinical Data Presentation at the Society for Immunotherapy of Cancer’s (SITC) 2021 Annual Meeting
Company to host conference call and webcast on Friday, November 12, 2021 at 8:30 a.m. ETCAMBRIDGE, Mass., Nov. 09, 2021...
Apexigen To Host Key Opinion Leader Webinar on Sotigalimab in Post-Anti-PD-(L)1 Melanoma
-Webinar to be held Friday, November 19, 2021 at 11:00 a.m. ET- -Featuring Harriet Kluger, M.D., renowned researcher, medical oncologist...
RNA Disease Diagnostics Secures Exclusive License to Ground-Breaking RNA-Based Molecular Lateral Flow Assay Technology
- License Enables Development of RNADD’s AntiSense Molecular Diagnostic Platform for Home-Use Infectious Disease Testing - BALTIMORE, Nov. 09, 2021 (GLOBE NEWSWIRE)...
ORYZON to Present New Clinical Data and Corporate Updates at International Conferences in November and December
Jefferies London Healthcare Conference 2021Evercore ISI 4th Annual HealthCONx Conference 202163th American Society of Hematology 2021 Congress (ASH-2021)MADRID, Spain and...
Rain Therapeutics Plans Phase 2 Merkel Cell Carcinoma Clinical Trial (MANTRA-3) of Milademetan
The Merkel cell trial will be prioritized over the previously planned Phase 2 trial in patients with intimal sarcoma, and...
Tempest to Present at Two Upcoming Investor Conferences in November
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing...
Shattuck Labs Announces Preliminary Clinical Data from Ongoing Phase 1 Clinical Trials of ARC Fusion Proteins SL-172154 and SL-279252
– SL-279252 (PD1-Fc-OX40L) demonstrates anti-tumor activity and evidence of dose-dependent immune activation in heavily pretreated, checkpoint experienced patients – –...
Vaccinex, Inc. to Present at the Clinical Trials on Alzheimer’s Disease (CTAD) Meeting
Live Presentation: Thursday, Nov. 11, 2021ROCHESTER, N.Y., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology...
MiNK Therapeutics Presents New Preclinical and Clinical Data on iNKT Cell Therapy Programs at SITC 2021
NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MiNK Therapeutics, a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization...
Mereo BioPharma to Present at Two Upcoming Investor Conferences
LONDON and REDWOOD CITY, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO) (“Mereo” or the...
Impel NeuroPharma to Present at the Guggenheim Securities 3rd Annual Neuro/Immunology Conference
SEATTLE, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Impel NeuroPharma, Inc. (NASDAQ: IMPL), a commercial-stage biopharmaceutical company developing transformative therapies for...
Avadel Pharmaceuticals to Present at Upcoming Investor Conferences in November
DUBLIN, Ireland, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on transforming medicines to...
New Research Demonstrates Clinical Utility of Daxor Corporation Blood Volume (BVA-100®) Diagnostic in Neurocritical Care
Data Presented at the NeuroCritical Care Society 19th Annual Meeting 2021 Data Highlight Daxor’s Diagnostic Changes Care in 69% of...
